|
1
|
Yamaguchi M and Yamamoto T: Purification
of calcium binding substance from soluble fraction of normal rat
liver. Chem Pharma Bull (Tokyo). 26:1915–1918. 1978. View Article : Google Scholar
|
|
2
|
Yamaguchi M and Sakurai T: Inhibitory
effect of calcium-binding protein regucalcin on
Ca2+-activated DNA fragmentation in rat liver nuclei.
FEBS Lett. 279:281–284. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shimokawa N and Yamaguchi M: Molecular
cloning and sequencing of the cDNA coding for a calcium-binding
protein regucalcin from rat liver. FEBS Lett. 327:251–255. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Misawa H and Yamaguchi M: The gene of
Ca2+-binding protein regucalcin is highly conserved in
vertebrate species. Int J Mol Med. 6:191–196. 2000.PubMed/NCBI
|
|
5
|
Yamaguchi M: Role of regucalcin in calcium
signaling. Life Sci. 66:1769–1780. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yamaguchi M: Role of regucalcin in
maintaining cell homeostasis and function (Review). Int J Mol Med.
15:371–389. 2005.PubMed/NCBI
|
|
7
|
Yamaguchi M: Regucalcin and cell
regulation: role as a suppressor in signal transduction. Mol Cell
Biochem. 353:101–137. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shimokawa N, Matsuda Y and Yamaguchi M:
Genomic cloning and chromosomal assignment of rat regucalcin gene.
Mol Cell Biochem. 151:157–163. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Thiselton DL, McDowall J, Brandau O,
Ramser J, d’Esposito F, Bhattacharya SS, Ross MT, Hardcastle AJ and
Meindl M: An integrated, functionally annotated gene map of the
DXS8026-ELK1 internal on human Xp11.3-Xp11.23: Potential hotspot
for neurogenetic disorders. Genomics. 79:560–572. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yamaguchi M, Makino R and Shimokawa N: The
5’ end sequences and exon organization in rat regucalcin gene. Mol
Cell Biochem. 165:145–150. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yamaguchi M: The transcriptional
regulation of regucalcin gene expression. Mol Cell Biochem.
346:147–171. 2011. View Article : Google Scholar
|
|
12
|
Yamaguchi M: Hormonal regulation of
regucalcin gene expression: Involvement in cell metabolism. Horm
Stud. 1:12013. View Article : Google Scholar
|
|
13
|
Yamaguchi M: Role of regucalcin in cell
nuclear regulation: Involvement as a transcription factor. Cell
Tissue Res. 354:331–341. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yamaguchi M: Suppressive role of
regucalcin in liver cell proliferation: Involvement in
carcinogenesis. Cell Prolif. 46:243–253. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yamaguchi M: The anti-apoptotic effect of
regucalcin is mediated through multisignaling pathways. Apoptosis.
18:1145–1153. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yamaguchi M: Regucalcin and metabolic
disorders: Osteoporosis and hyperlipidemia are induced in
regucalcin transgenic rats. Mol Cell Biochem. 341:119–133. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yamaguchi M and Murata T: Involvement of
regucalcin in lipid metabolism and diabetes. Metabolism.
62:1045–1051. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yamaguchi M: Regucalcin as a potential
biomarker for metabolic and neuronal diseases. Mol Cell Biochem.
391:157–166. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yamaguchi M: Involvement of regucalcin as
a suppressor protein in human carcinogenesis: insight into the gene
therapy. J Cancer Res Clin Oncol. Sep 18–2014.Epub ahead of print.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Murata T and Yamaguchi M: Alternatively
spliced variants of the regucalcin gene in various human normal and
tumor tissues. Int J Mol Med. 34:1141–1146. 2014.PubMed/NCBI
|
|
21
|
Misawa H, Inagaki S and Yamaguchi M:
Suppression of cell proliferation and deoxyribonucleic acid
synthesis in cloned rat hepatoma H4-II-E cells overexpressing
regucalcin. J Cell Biochem. 84:143–149. 2001. View Article : Google Scholar
|
|
22
|
Ninomiya I, Yamazaki K, Oyama K, Hayashi
H, Tajima H, Kitagawa H, Fushida S, Fujimura T and Ohta T:
Pioglitazone inhibits the proliferation and metastasis of human
pancreatic cancer cells. Oncol Lett. 8:2709–2714. 2014.PubMed/NCBI
|
|
23
|
Sipos B, Möser S, Kalthoff H, Török V,
Löhr M and Klöppel G: A comprehensive characterization of
pancreatic ductal carcinoma cell lines: Towards the establishment
of an in vitro reseach platform. Virchows Arch. 442:444–452.
2003.PubMed/NCBI
|
|
24
|
Yamaguchi M and Isogai M: Tissue
concentration of calcium-binding protein regucalcin in rats by
enzyme-linked immunoadsorbent assay. Mol Cell Biochem. 122:65–68.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee ZH, Kwack K, Kim KK, Lee SH and Kim
HH: Activation of c-Jun N-terminal kinase and activator protein 1
by receptor activator of NF-kappaB. Mol Pharmacol. 58:1536–1545.
2000.PubMed/NCBI
|
|
26
|
Cano-Abad MF, Villarroya M, García AG,
Gabilan NH and Lopez MG: Calcium entry through L-type calcium
channels causes mitochondrial disruption and chromaffin cell death.
J Biol Chem. 276:39695–39704. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen S, Wang Y, Ruan W, Wang X and Pan C:
Reversing multidrug resistance in hepatocellular carcinoma cells by
inhibiting extracellular signal-regulated kinase/mitogen-activated
protein kinase signaling pathway activity. Oncol Lett. 8:2333–2339.
2014.PubMed/NCBI
|
|
28
|
Chen QW, Edvinsson and Xu CB: Role of
ERK/MAPK in endothelin receptor signaling in human aortic smoth
muscle cells. BMC Cell Biol. 10:522009. View Article : Google Scholar
|
|
29
|
Serrano-Nascimento C, da Silva Teixeira S,
Nicola JP, Nachbar RT, Masini-Repiso AM and Nunes MT: The acute
inhibitory effect of iodide excess on sodium/iodide symporter
expression and activity involves the PI3K/Akt signaling pathway.
Endocrinology. 155:1145–1156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Palangat M, Grass JA, Langelier MF,
Coulombe B and Landick R: The RPB2 flap loop of human RNA
polymerase II is dispensable for transcription initiation and
elongation. Mol Cell Biol. 31:3312–3325. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tang SC and Chen YC: Novel therapeutic
targets for pancreatic cancere. World J Gastroenterol.
20:10825–10844. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Maia C, Santos C, Schmitt F and Socorro S:
Regucalcin is under- expressed in human breast and prostate
cancers: Effect of sex steroid hormones. J Cell Biochem.
107:667–676. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yamaguchi M and Daimon Y: Overexpression
of regucalcin suppresses cell proliferation in cloned rat hepatoma
H4-II-E cells: Involvement of intracellular signaling factors and
cell cycle-related genes. J Cell Biochem. 95:1169–1177. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nakagawa T, Sawada N and Yamaguchi M:
Overexpression of regucalcin suppresses cell proliferation of
cloned normal rat kidney proximal tubular epithelial NRK52E cells.
Int J Mol Med. 16:637–643. 2005.PubMed/NCBI
|
|
35
|
Tsurusaki Y and Yamaguchi M:
Overexpression of regucalcin modulates tumor-related gene
expression in cloned rat hepatoma H4-II-E cells. J Cell Biochem.
90:619–626. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tsurusaki Y and Yamaguchi M: Role of
regucalcin in liver nuclear function: Binding of regucalcin to
nuclear protein or DNA and modulation of tumor-related gene
expression. Int J Mol Med. 14:277–281. 2004.PubMed/NCBI
|
|
37
|
Yamaguchi M, Mori S and Kato S:
Calcium-binding protein regucalcin is an activator
(Ca2+-Mg2+)-adenosine triphosphatase in the
plasma membranes of rat liver. Chem Pharm Bull (Tokyo).
36:3532–3539. 1988. View Article : Google Scholar
|
